Solution
Our advanced analytics, supported by our data scientists, health economics and value proposition experts, create a unique environment, that brings a number of tools and solutions together.
Epidemiology - A detailed understanding of population health, based on a disease status within the UK. We provide a clear view of where medical device companies and stakeholders can better support the NHS and patients.
Costing Models - Providing a robust and well tested advanced analysis. Together with the option of an interactive tool, to establish pathway/treatment costs, to support the cost justification of adopting the new medical technology. Using NHS metrics and data to drive a cost comparison between the standard of care and the new approach of a procedure, diagnostic or delivery of service. Our data scientists will work closely with you to understand all the product benefits for that NHS pathway.
Business Case/Value Proposition - A report which supports the adoption of new service solutions or medical device technology, demonstrating the value proposition to the NHS, with the key benefits of change. Both from a qualitative and quantitative viewpoint, together with the financial elements supporting the decision-making process with relevant stakeholders.
Benefits
Epidemiology - The paucity of data on the use of medical devices between primary and secondary care. Having real-world data to better demonstrate the patient outcome opportunities by changing, enhancing or staying the same regarding the clinical pathway. The difficulty in establishing if there is an unfulfilled need for medical device companies, at early stages, which aligns with business cases for NHS Trusts and CCGs (Funders).
Costing Models - The difficulty in accurately and consistently providing a clear and transparent cost-benefit analysis for the NHS. Understanding how the procedures are funded and how the CCGs (Funders) are implementing the policy to better manage costs.
Business Case / Value Proposition – Most medical device companies either don’t speak the language of the NHS and or know how to present the business case for stakeholders. Having this type of document, allows medical device companies and stakeholders to relate to their part of the business case, with a take away for each. Therefore showing a collective view of the benefits and opportunities for all.
Stakeholders
- Private Hospitals
- NHS
- Med-Tech
- Venture Capitalists
- Health Economists
- Pharmaceuticals
- Private Medical Insurance
Related Articles
blog
AMBLor receives NICE Medtech innovation briefing
It is our pleasure to announce that AMBLor® by AMLo Biosciences has received NICE advice under the MedTech Innovation briefing program (MIB…
blog
Granulox receives NICE Medtech innovation briefing
Another fantastic achievement for us, as we have great pleasure to announce that Granulox® by Mölnlycke Health Care has received…
blog
Merry Christmas and Happy New Year
By Richard Tuson
11:02pm 17th December 2020
After a year like no other, I want to thank you for all your support and hope the New Year…